The U.S. has passed a grim milestone: more than a quarter-million deaths from COVID-19.
As the numbers continue to rise here and around the globe, all eyes are on a vaccine — with encouraging news on that front.
Pfizer is now seeking approval for the emergency use of a new vaccine, and Moderna is said to be not far behind. But getting a vaccine approved, and then delivering it, are two very big — and different — challenges.
Also, with the COVID-19 vaccine, it has to get to every remote corner of the globe by airplane.
For more insights, The World’s Carol Hills spoke to Glyn Hughes, the global head of cargo for the International Air Transport Association.